lorazepam macure 4 mg/ml solution for injection
macure pharma aps - lorazepam - solution for injection - 4 milligram(s)/millilitre - lorazepam
isoprenaline hydrochloride macure 0.2 mg/ml concentrate for solution for infusion
macure pharma aps - isoprenaline hydrochloride - concentrate for solution for infusion - 0.2 milligram(s)/millilitre - isoprenaline
isoprenaline macure 0.2 mg/ml concentrate for solution for infusion
macure pharma aps hejrevej 39, dk-2400 copenhagen nv , denmark - isoprenaline hydrochloride - concentrate for solution for infusion - isoprenaline hydrochloride 0.2 mg/ml - cardiac therapy
flumacure 75 75mg/capsule
pharma house pharmaceuticals india - 10's blister - capsule - 75mg/capsule - infections-antiviral
isoprenaline hcl macure 0.2 mg/ml inf. sol. (conc.) i.v. amp.
macure pharma aps - isoprenaline hydrochloride 0,2 mg/ml - eq. isoprenaline 0,17 mg/ml - concentrate for solution for infusion - 0,2 mg/ml - isoprenaline hydrochloride 0.2 mg/ml - isoprenaline
lorazepam macure 4 mg/ml inj. sol. i.v./i.m. amp.
macure pharma aps - lorazepam 4 mg/ml - solution for injection - 4 mg/ml - lorazepam 4 mg/ml - lorazepam
homacure capsule
psm pharmaceuticals ltd 1422 - 00606 - paracetamol bp, phenylephrine hcl bp, - capsule - paracetamol bp 300 mg, phenylephrine hcl bp 10 - other cold preparations
isoprenaline macure isoprenaline hydrochloride 1 mg/5 ml solution for injection ampoule
juno pharmaceuticals pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; water for injections; sodium hydroxide; hydrochloric acid; sodium chloride; citric acid monohydrate; disodium edetate - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications.) for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.) for bronchospasm occurring during anaesthesia. as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use)
bomacure
elanco new zealand - cephapirin benzathine - cephapirin benzathine 33.7 g/kg - antibiotic
bimacure 500mg intrauterine suspension for cattle
bimeda animal health limited - cefapirin benzathine - intrauterine suspension - cefapirin